[india-drug] Response to use of anti retroviral drugs in India

["Dr. Rahman" <rahmansz@sancharnet.in>]

Response to use of anti retroviral drugs in India
----------------------------------------------------

Dear Idrug participants,

Its good to learn that the Government of India is committed to 
providing ARV drugs for HIV in 100,000 people living with AIDS in 2004.
In relation to distribution of drug or Use of anti retroviral drugs in
India, we should recognize that the cost availability and affordability
of drugs and related technology are significant factors to be reviewed
and addressed in all aspects and that there is a need to reduce the
cost of these drugs and technologies in close collaboration with the
private sector and pharmaceutical companies; and acknowledge that the
lack of affordable pharmaceuticals and of feasible supply structures
and health systems continue to hinder an effective response to HIV/AIDS
in India, especially for the poorest people and recalling efforts to
make drugs available at low prices for those in need.

Looking forward for further comments.

With regards,
S. Z. Rahman


Syed Ziaur Rahman, MD
Lecturer, Deptt. of Pharmacology
Jawaharlal Nehru Medical College
Aligarh Muslim University
Aligarh-202002 INDIA
Tel. #: +91-571-2400452 (R); 2720358 (W)




________________________________________________________________________
Yahoo! India Mobile: Download the latest polyphonic ringtones.
Go to http://in.mobile.yahoo.com

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org